[Event Report] Joint Japan/ UK Science and Policy Workshop (March 4-5, 2024, Shinjuku-ku, Tokyo)
date : 4/2/2024
Tags: AMR
![[Event Report] Joint Japan/ UK Science and Policy Workshop (March 4-5, 2024, Shinjuku-ku, Tokyo)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20240304_AMR_01-scaled-1.jpg)
On March 4 and 5, Health and Global Policy Institute (HGPI) Manager Ms. Yui Kohno presented at the Joint Japan/ UK Science and Policy Workshop which was held in Shinjuku-ku, Tokyo, Japan.
The Joint Japan/ UK Science and Policy Workshop was hosted by the National Centre for Global Health and Medicine (NCGM) and Sir Howard Dalton Centre (HDC), and the University of Warwick. The workshop gathered stakeholders from science, policy, academia, industry, and philanthropy to address how new national and international cross-sectoral partnerships might work together in a sustainable manner for future antibiotic discovery.
Session 3 (Part 1) featured speakers on the theme of “Industry-Academia Collaboration for Sustainable Capacity Building in Antibiotic Drug Discovery – Next Generation Scientists, Lessons from Past Experiences, and Future Plans.”
The lecture concluded with a panel discussion and Q&A.
Chair
UK – Annette von Delft (Centre for Medicines Discovery, Oxford University)
Japan – Yui Kohno (Health and Global Policy Institute (HGPI))
Panelists (Speaking Order)
Dave Powell (Chief Scientific Officer, LIfeArc)
Manabu Sumi (Cabinet Councillor, Cabinet Agency for Infectious Disease Crisis Management, Cabinet Secretariat)
Takuko Sawada (Director of the Board and Executive Vice President, Shionogi & Co.)
Munehiro Asally (Associate Professor, School of Life Sciences, University of Warwick)
Top Research & Recommendations Posts
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Cancer Control Project “Policy Recommendations on Addressing Regional Disparities in Breast Cancer Care” (January 31, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Discussion Points] Intractable & Rare Diseases Project Discussion Paper “Intractable & Rare Diseases 2025: 10 Years After the Passing of the Intractable Diseases Act, Toward a Co-created Future” (Mar 28, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Public Comment Submission] “2050 Tokyo Strategy: Making Tokyo Even Better (Draft)” (March 3, 2025)
- [Policy Recommendations] Dementia Project Information Packet for Local Government Officials “Dementia Policies for Our City: Taking the First Step in Promoting Future Measures for Dementia” (March 17, 2025)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
Featured Posts
-
2025-03-26
[Registration Open] (Webinar) The 132nd HGPI Seminar “Considering the Ideal Evidence-Based Immunization and Vaccination Policies” (April 25, 2025)
-
2025-04-02
[Registration Open] Public Event “The Patient and Citizen Lived Experience Forum 2025” (May 17, 2025)
-
2025-04-17
[Registration Open] (Webinar) The 134th HGPI Seminar “Understanding Evidence-Based Dietary Guidelines: Leveraging the Dietary Reference Intakes for Japanese” (May 28, 2025)